Digital image analysis of the distribution of proliferating cell nuclear antigen in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma

Digestive Diseases and Sciences

Volumn 47, Issue 7, 2002, Pages 1644-1648

  Lake Bakaar, Gerond ^a   Mazzoccoli, Vito ^a   Ruffini, Lynda ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cirrhosis; Digital image analysis; Hepatitis C; Hepatocyte turnover; Proliferating cell nuclear antigen

Indexed keywords

BISBENZIMIDE; CYCLINE;

ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

CARCINOMA, HEPATOCELLULAR; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0036315363     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015800126283     Document Type: Article

References (26)

1. Effect of interferon alpha on the dynamics of hepatitis C virus turnover in vivo
2. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alpha
3. Viral dynamics of hepatitis C early after orthopic liver transplantation: Evidence for rapid turnover of serum virions
4. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-a therapy
5. Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alpha on viral turnover
6. HCV viral dynamics during therapy with interferon-a-2b plus or minus ribavirin: Correlation with ALT suggests ribavirin may prevent de novo re-infection?
7. Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy
8. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery
9. Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma
10. Liver regeneration, liver cancers and cyclins
11. Nitric oxide and chronic HCV and HiV infections
12. Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis
13. Relationship between hepatocyte proliferation and hepatitis delta virus replication in neoplastic and non-neoplastic liver tissues
14. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: The role of etiology, disease activity, iron, and lipid peroxidation
15. Proliferative activity of hepatocytes in chronic viral hepatitis is revealed by immunohistochemistry for proliferating cell nuclear antigen
16. Telomere length in human liver diseases
17. Telomere shortening in in chronic liver diseases
18. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease
19. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis
20. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues
21. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area
22. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
23. Liver cell proliferation in patients with chronic hepatitis C is reduced by interferon therapy
24. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses
25. The effect of retreatment with interferon-alpha on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
26. Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B or hepatitis C virus infection